Agnès Veyradier Selected Research

Agnès Veyradier Research Topics

Disease

81	Thrombotic Thrombocytopenic Purpura 03/2024 - 04/2002
31	Thrombotic Microangiopathies 12/2023 - 04/2002
11	acquired Thrombotic thrombocytopenic purpura 11/2020 - 01/2012
10	Thrombocytopenia (Thrombopenia) 01/2020 - 10/2004
9	Neoplasms (Cancer) 12/2018 - 04/2002
8	Hemolytic-Uremic Syndrome 08/2023 - 04/2002
8	Hemolytic Anemia 01/2020 - 10/2004
7	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2006
6	Infections 05/2016 - 05/2002
5	Hemorrhage 01/2021 - 03/2013
4	Atypical Hemolytic Uremic Syndrome 05/2022 - 03/2003
4	Thrombosis (Thrombus) 11/2020 - 01/2003
4	von Willebrand Diseases (von Willebrand's Disease) 12/2019 - 11/2005
3	Sepsis (Septicemia) 08/2023 - 04/2007
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 08/2021 - 10/2004
3	Hemolysis 01/2021 - 04/2002
3	Critical Illness (Critically Ill) 01/2021 - 01/2018
3	Anemia 06/2019 - 04/2017
3	Diarrhea 01/2018 - 05/2002
2	Hypertension (High Blood Pressure) 05/2022 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Pre-Eclampsia (Preeclampsia) 11/2020 - 07/2011
2	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 07/2004
2	Cytopenia 12/2019 - 04/2017
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 04/2014
2	Ischemia 01/2017 - 01/2009
2	Type 2 von Willebrand Disease 01/2016 - 11/2005
2	Disseminated Intravascular Coagulation 10/2015 - 11/2013
2	HIV Infections (HIV Infection) 03/2012 - 07/2004
2	Connective Tissue Diseases (Connective Tissue Disease) 03/2012 - 05/2002
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2024
1	Hypotension (Low Blood Pressure) 11/2023
1	Myasthenia Gravis 01/2023
1	Rheumatoid Arthritis 01/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	Guillain-Barre Syndrome 01/2023
1	Systemic Vasculitis 01/2023
1	Pemphigus (Pemphigus Vulgaris) 01/2023
1	Glomerulonephritis 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2021
1	Ischemic Stroke 08/2021
1	Hemophilia A (Haemophilia) 02/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	COVID-19 01/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Eclampsia 11/2020
1	Paralysis (Palsy) 01/2020

Drug/Important Bio-Agent (IBA)

52	thiamine triphosphorate (TTP)IBA 12/2023 - 05/2002
21	von Willebrand FactorIBA 04/2023 - 04/2002
17	Metalloproteases (Metalloproteinases)IBA 01/2021 - 05/2002
14	ThrombospondinsIBA 01/2021 - 01/2009
14	DisintegrinsIBA 01/2021 - 01/2009
13	AutoantibodiesIBA 01/2023 - 03/2006
13	Rituximab (Mabthera)FDA Link 01/2021 - 02/2004
9	ADAMTS13 ProteinIBA 04/2023 - 04/2002
7	AntibodiesIBA 12/2023 - 07/2004
5	caplacizumabIBA 06/2023 - 11/2019
4	AntigensIBA 03/2024 - 07/2011
4	Immunoglobulin G (IgG)IBA 01/2023 - 05/2016
4	Shiga Toxin (Shigella Toxin)IBA 05/2022 - 05/2002
3	Polysaccharides (Glycans)IBA 12/2023 - 01/2018
3	Hemostatics (Antihemorrhagics)IBA 01/2021 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
3	EnzymesIBA 11/2020 - 03/2009
3	Glycoproteins (Glycoprotein)IBA 12/2019 - 03/2016
3	AnticoagulantsIBA 06/2019 - 01/2018
3	Fibrinogen (Factor I)FDA Link 01/2018 - 03/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2018
2	CreatinineIBA 11/2021 - 01/2018
2	Complement System Proteins (Complement)IBA 11/2020 - 03/2009
2	SteroidsIBA 01/2020 - 02/2014
2	Hemoglobins (Hemoglobin)IBA 12/2019 - 01/2018
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2018 - 03/2012
2	Antinuclear AntibodiesIBA 04/2017 - 07/2004
2	Dacarbazine (DIC)FDA LinkGeneric 10/2015 - 11/2013
2	Interleukin-6 (Interleukin 6)IBA 11/2013 - 07/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012 - 02/2004
1	Fibrinolysin FDA Link 01/2024
1	MagnesiumIBA 11/2023
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023
1	Antiphospholipid AntibodiesIBA 08/2021
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2021
1	Factor VIII (Coagulation Factor VIII)IBA 02/2021
1	eculizumab FDA Link 01/2021
1	Gemcitabine FDA Link 01/2021
1	EpitopesIBA 11/2020
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020

Therapy/Procedure

10	Plasma Exchange 01/2020 - 10/2002
8	Therapeutics 08/2021 - 03/2006
6	Drug Therapy (Chemotherapy) 01/2021 - 04/2002
3	Transplantation 04/2007 - 05/2002
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021 - 01/2018
2	Kidney Transplantation 01/2019 - 10/2002
2	Salvage Therapy 08/2016 - 11/2012
2	Organ Transplantation 05/2016 - 06/2006
2	Central Venous Catheters 04/2014 - 01/2003
1	Off-Label Use 01/2020